Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

Clinical trial NCT01266265 · COMPLETED

Trial details

NCT number: NCT01266265
Sponsor: United Therapeutics
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Arterial Hypertension

Start date: 2010-12-01
Primary completion: 2014-12-01
Enrollment: 1333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.